Atlas Trials

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Clinical trial NCT00117286 · COMPLETED

Trial details

NCT number
NCT00117286
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2005-03-01
Primary completion
2009-09-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.